-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IpnQ96XB+5z54cTOyiUEFU49Tl24G+E5U6vp6bxZ17meJQMNYF4/hiZsqzhktWqS +yebTbKam82yU8+sL520sA== 0000897069-07-001411.txt : 20070615 0000897069-07-001411.hdr.sgml : 20070615 20070615160329 ACCESSION NUMBER: 0000897069-07-001411 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070613 FILED AS OF DATE: 20070615 DATE AS OF CHANGE: 20070615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFMEISTER THOMAS CENTRAL INDEX KEY: 0001307464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 07923159 BUSINESS ADDRESS: BUSINESS PHONE: 301-280-4555 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 cmw2892_ex.xml X0202 4 2007-06-13 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001307464 HOFMEISTER THOMAS TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 VP of Finance and CAO Common Stock 2007-06-13 4 S 0 100 11.20 D 12400 D Common Stock 2007-06-13 4 S 0 100 11.21 D 12300 D Common Stock 2007-06-13 4 S 0 590 11.22 D 11710 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. Includes 9,210 shares of restricted common stock remaining from an initial grant of 10,000 shares of restricted common stock, of which 25% vested on 6/12/07 and which cumulatively vest to the extent of 25% each year thereafter and 2,500 shares of common stock remaining from an initial grant of 5,000 shares of restricted common stock, of which 25% vested on each of October 29, 2005 and October 29, 2006, and which cumulatively vests to the extent of 25% each year thereafter. /s/ Arthur H. Bill, Attorney-in-Fact 2007-06-14 -----END PRIVACY-ENHANCED MESSAGE-----